These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 3917456

  • 1. Idiopathic growth hormone (GH) deficiency, and GH deficiency secondary to hypothalamic germinoma: effect of single and repeated administration of human GH-releasing factor (hGRF) on plasma GH level and endogenous hGRF-like immunoreactivity level in cerebrospinal fluid.
    Chihara K, Kashio Y, Abe H, Minamitani N, Kaji H, Kita T, Fujita T.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):269-78. PubMed ID: 3917456
    [Abstract] [Full Text] [Related]

  • 2. Presence of growth hormone-releasing factor-like immunoreactivity in human cerebrospinal fluid.
    Kashio Y, Chihara K, Kaji H, Minamitani N, Kita T, Okimura Y, Abe H, Iwasaki J, Fujita T.
    J Clin Endocrinol Metab; 1985 Feb; 60(2):396-8. PubMed ID: 3917461
    [Abstract] [Full Text] [Related]

  • 3. The effects of acute and chronic growth hormone (GH) administration on GH secretion in patients with idiopathic GH deficiency.
    Hanew K, Goh M, Sato S, Shimizu Y, Sasaki A, Aida M, Yoshinaga K.
    J Clin Endocrinol Metab; 1988 Apr; 66(4):715-21. PubMed ID: 3126213
    [Abstract] [Full Text] [Related]

  • 4. Effect of growth hormone (GH)-releasing hormone (GRH) on plasma GH in relation to magnitude and duration of GH deficiency in 26 children and adults with isolated GH deficiency or multiple pituitary hormone deficiencies: evidence for hypothalamic GRH deficiency.
    Schriock EA, Lustig RH, Rosenthal SM, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1984 Jun; 58(6):1043-9. PubMed ID: 6427257
    [Abstract] [Full Text] [Related]

  • 5. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
    Vance ML, Kaiser DL, Evans WS, Furlanetto R, Vale W, Rivier J, Thorner MO.
    J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
    [Abstract] [Full Text] [Related]

  • 6. Plasma GH and somatomedin C responses to single and repeated administrations of human growth hormone releasing factor (hGRF).
    Takano K, Hizuka N, Shizume K, Hirose N, Ling NC.
    Endocrinol Jpn; 1985 Feb; 32(1):73-80. PubMed ID: 3926476
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone (GH)-releasing factor stimulates hypothalamic somatostatin release: an inhibitory feedback effect on GH secretion.
    Katakami H, Arimura A, Frohman LA.
    Endocrinology; 1986 May; 118(5):1872-7. PubMed ID: 3084210
    [Abstract] [Full Text] [Related]

  • 8. Plasma growth hormone (GH) response to GH-releasing factor in normal children with short stature and patients with pituitary dwarfism.
    Takano K, Hizuka N, Shizume K, Asakawa K, Miyakawa M, Hirose N, Shibasaki T, Ling NC.
    J Clin Endocrinol Metab; 1984 Feb; 58(2):236-41. PubMed ID: 6420432
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone (GH) responses to GH-releasing hormone during pubertal development in normal boys and girls: comparison to idiopathic short stature and GH deficiency.
    Gelato MC, Malozowski S, Caruso-Nicoletti M, Ross JL, Pescovitz OH, Rose S, Loriaux DL, Cassorla F, Merriam GR.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):174-9. PubMed ID: 3086356
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of growth hormone (GH) and somatomedin C in idiopathic GH-deficient subjects by intermittent pulsatile administration of synthetic human pancreatic tumor GH-releasing factor.
    Borges JL, Blizzard RM, Evans WS, Furlanetto R, Rogol AD, Kaiser DL, Rivier J, Vale W, Thorner MO.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):1-6. PubMed ID: 6427267
    [Abstract] [Full Text] [Related]

  • 11. Effect of oral glucose administration on plasma growth hormone-releasing hormone (GHRH)-like immunoreactivity levels in normal subjects and patients with idiopathic GH deficiency: evidence that GHRH is released not only from the hypothalamus but also from extrahypothalamic tissue.
    Kashio Y, Chihara K, Kita T, Okimura Y, Sato M, Kadowaki S, Fujita T.
    J Clin Endocrinol Metab; 1987 Jan; 64(1):92-7. PubMed ID: 3097059
    [Abstract] [Full Text] [Related]

  • 12. Plasma growth hormone (GH) and somatomedin C response to continuous growth hormone-releasing factor (GRF) infusion in patients with GH deficiency.
    Hizuka N, Takano K, Shizume K, Tanaka I, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Sep; 110(1):17-23. PubMed ID: 2863915
    [Abstract] [Full Text] [Related]

  • 13. A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone.
    Ghigo E, Imperiale E, Boffano GM, Mazza E, Bellone J, Arvat E, Procopio M, Goffi S, Barreca A, Chiabotto P.
    J Endocrinol Invest; 1990 Apr; 13(4):307-16. PubMed ID: 2115060
    [Abstract] [Full Text] [Related]

  • 14. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation.
    Arsenijevic Y, Rivest RW, Eshkol A, Sizonenko PC, Aubert ML.
    Endocrinology; 1987 Oct; 121(4):1487-96. PubMed ID: 2888646
    [Abstract] [Full Text] [Related]

  • 15. Plasma growth hormone (GH) response to GH-releasing factor (SM-8144) in children of short stature and patients with GH deficiency.
    Takano K, Shizume K, Imura H, Irie M, Kumahara Y, Shimizu N.
    Endocrinol Jpn; 1987 Feb; 34(1):117-28. PubMed ID: 3111840
    [Abstract] [Full Text] [Related]

  • 16. Effect of growth hormone-releasing factor on plasma growth hormone, prolactin and somatomedin C in hypopituitary and short normal children.
    Van Vliet G, Bosson D, Robyn C, Craen M, Malvaux P, Vanderschueren-Lodeweyckx M, Wolter R.
    Horm Res; 1985 Feb; 22(1-2):32-45. PubMed ID: 3928475
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [Abstract] [Full Text] [Related]

  • 18. The effect of pulsatile administration, continuous infusion, and diurnal variation on the growth hormone (GH) response to GH-releasing hormone in normal men.
    Hulse JA, Rosenthal SM, Cuttler L, Kaplan SL, Grumbach MM.
    J Clin Endocrinol Metab; 1986 Oct; 63(4):872-8. PubMed ID: 3091629
    [Abstract] [Full Text] [Related]

  • 19. Synthetic growth hormone-releasing hormone (GHRH 1-44) in the differential diagnosis between hypothalamic and pituitary GH deficiency.
    Bozzola M, Tatò L, Cisternino M, Nava C, Valtorta A, Chiesa M, Severi F, Gaburro D.
    J Endocrinol Invest; 1986 Dec; 9(6):503-6. PubMed ID: 3106460
    [Abstract] [Full Text] [Related]

  • 20. Somatostatin pretreatment enhances growth hormone (GH) responsiveness to GH-releasing hormone: a potential new diagnostic approach to GH deficiency.
    Tzanela M, Guyda H, Van Vliet G, Tannenbaum GS.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2487-94. PubMed ID: 8675565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.